Partnership for an Equitable Medical Future
Sanofi is a leading international pharmaceutical company, based on research and development and artificial intelligence-driven innovation. We are committed to improving the lives of people around the world and work tirelessly to transform science into medical reality – through breakthrough treatments and innovative solutions.
We develop medications and vaccines for dermatological, respiratory, gastroenterological, and immunological diseases, and advance the field of medicine in Israel and worldwide.
Our commitment to patients drives us toward innovation, developing local collaborations, and making advanced medical technologies accessible in Israel.
In 2025, Sanofi launched 52 clinical trials in Israel, representing a significant investment in the local economy.
At the center of our activities stands Sanofi's Patient Charter, which defines patients as full partners in all stages of our work: from treatment development, through decision-making, to strengthening patient organizations that represent the voice of patients.
We are proud of our partnership with the Haverim L'Refuah association, which embodies values of medical excellence alongside equity. The organization's dedicated work is inspiring and contributes greatly to strengthening the medical community in Israel.
Sanofi is committed to continuing to work for patients in Israel, to advance medical innovation, and to bring solutions for better and healthier lives.
Dr. Noa Geffen
CEO Sanofi Israel
